DATE,PATIENT,ENCOUNTER,CODE,DESCRIPTION,BASE_COST
2016-04-08T00:52:57Z,4e6f79d7-252b-02fc-80c1-47e07b1a495c,a35709cd-db1f-9e40-81b9-82874aae739b,140,Influenza  seasonal  injectable  preservative free,136.0
2016-04-08T00:52:57Z,4e6f79d7-252b-02fc-80c1-47e07b1a495c,a35709cd-db1f-9e40-81b9-82874aae739b,113,Td (adult)  5 Lf tetanus toxoid  preservative free  adsorbed,136.0
2016-04-08T00:52:57Z,4e6f79d7-252b-02fc-80c1-47e07b1a495c,a35709cd-db1f-9e40-81b9-82874aae739b,43,Hep B  adult,136.0
2016-04-08T00:52:57Z,4e6f79d7-252b-02fc-80c1-47e07b1a495c,a35709cd-db1f-9e40-81b9-82874aae739b,114,meningococcal MCV4P,136.0
2019-04-12T00:52:57Z,4e6f79d7-252b-02fc-80c1-47e07b1a495c,95b0965f-1cdf-fe34-258f-a11cca7078ad,140,Influenza  seasonal  injectable  preservative free,136.0
2021-01-22T00:52:57Z,4e6f79d7-252b-02fc-80c1-47e07b1a495c,cbcab2c0-2d8e-eb83-b57d-2823833b2c9d,207,COVID-19  mRNA  LNP-S  PF  100 mcg/0.5mL dose or 50 mcg/0.25mL dose,136.0
2021-02-19T00:52:57Z,4e6f79d7-252b-02fc-80c1-47e07b1a495c,ed71c7be-f3df-fd76-b5f0-f8344cd5c9f8,207,COVID-19  mRNA  LNP-S  PF  100 mcg/0.5mL dose or 50 mcg/0.25mL dose,136.0
2022-04-15T00:52:57Z,4e6f79d7-252b-02fc-80c1-47e07b1a495c,5790a3f3-8a95-60f4-3aac-6b905da7284d,140,Influenza  seasonal  injectable  preservative free,136.0
2023-02-17T00:52:57Z,4e6f79d7-252b-02fc-80c1-47e07b1a495c,d2f28c31-cc11-651a-788f-bf27c10aac06,140,Influenza  seasonal  injectable  preservative free,136.0
